Enovis Corp
NYSE:ENOV
Intrinsic Value
Enovis Corp is a US-based company operating in Health Care Equipment & Supplies industry. [ Read More ]
The intrinsic value of one ENOV stock under the Base Case scenario is 69.81 USD. Compared to the current market price of 54.92 USD, Enovis Corp is Undervalued by 21%.
Valuation Backtest
Enovis Corp
Run backtest to discover the historical profit from buying and selling ENOV stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Enovis Corp
Current Assets | 896.5m |
Cash & Short-Term Investments | 36.2m |
Receivables | 291.5m |
Other Current Assets | 568.8m |
Non-Current Assets | 3.6B |
PP&E | 334.3m |
Intangibles | 3.2B |
Other Non-Current Assets | 90.3m |
Current Liabilities | 369.6m |
Accounts Payable | 132.5m |
Accrued Liabilities | 219.8m |
Other Current Liabilities | 17.3m |
Non-Current Liabilities | 721.3m |
Long-Term Debt | 466.2m |
Other Non-Current Liabilities | 255.2m |
Earnings Waterfall
Enovis Corp
Revenue
|
1.7B
USD
|
Cost of Revenue
|
-713.8m
USD
|
Gross Profit
|
993.4m
USD
|
Operating Expenses
|
-973.5m
USD
|
Operating Income
|
19.9m
USD
|
Other Expenses
|
-53.1m
USD
|
Net Income
|
-33.3m
USD
|
Free Cash Flow Analysis
Enovis Corp
ENOV Profitability Score
Profitability Due Diligence
Enovis Corp's profitability score is 46/100. The higher the profitability score, the more profitable the company is.
Score
Enovis Corp's profitability score is 46/100. The higher the profitability score, the more profitable the company is.
ENOV Solvency Score
Solvency Due Diligence
Enovis Corp's solvency score is 49/100. The higher the solvency score, the more solvent the company is.
Score
Enovis Corp's solvency score is 49/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
ENOV Price Targets Summary
Enovis Corp
According to Wall Street analysts, the average 1-year price target for ENOV is 76.7 USD with a low forecast of 65.65 USD and a high forecast of 86.1 USD.
Ownership
ENOV Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Shareholder Return
ENOV Price
Enovis Corp
Average Annual Return | -22.78% |
Standard Deviation of Annual Returns |
N/A
|
Max Drawdown | -38% |
Market Capitalization | 3B USD |
Shares Outstanding | 55 000 000 |
Percentage of Shares Shorted | 9.05% |
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Enovis Corp is a US-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in Wilmington, Delaware and currently employs 16,200 full-time employees. The company went IPO on 2008-05-08. Enovis Corporation, formerly Colfax Corporation, is a medical technology company that provides orthopedic care and fabrication technology products and services under DJO brand. The Company’s segments include Fabrication Technology and Medical Technology. The Fabrication Technology segment formulates, develops, manufactures and supplies consumable products and equipment, including cutting, joining, and automated welding products, as well as gas control equipment. Its fabrication technology products are marketed under several brands. The Medical Technology segment develops, manufactures and distributes medical devices and services across the continuum of patient care from injury prevention to joint replacement to the rehabilitation after surgery, injury from degenerative disease, enabling people to regain or maintain their natural motion. Its products are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, and others.
Contact
IPO
Employees
Officers
The intrinsic value of one ENOV stock under the Base Case scenario is 69.81 USD.
Compared to the current market price of 54.92 USD, Enovis Corp is Undervalued by 21%.